Dr. Carthon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365b Clifton Rd Ne Ste B4300
Winship Cancer Institute Of Emory University
Atlanta, GA 30322Phone+1 404-778-1900- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
- Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
- Harvard Medical SchoolClass of 2005
Certifications & Licensure
- GA State Medical License 2011 - 2025
- TX State Medical License 2008 - 2013
- MA State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Axitinib and Temsirolimus in Solid Tumors Start of enrollment: 2011 Oct 01
- Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.Miller, E., Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet A Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang ...> ;Cancer. 2024 May 1
- Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.Jon A Hoin, Shantoria J Brown, Lynn M Durham, L Crain Garrot, Brian M Rivers, Cindy T Snyder, Sheryl Gordon Ann Gabram-Mendola, Bradley C Carthon, Sharad A Ghamande, A...> ;Frontiers in Health Services. 2024 Jan 1
- 1 citationsImmune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.Sanda, G., Shabto, J., Goyal, S., Liu, Y., Martini, D., Nazha, B., Brown, J., Yantorni, L., Anne Russler, G., Caulfield, S., Joshi, S., Narayan, V., Kissick, H., Ogan,...> ;The Oncologist. 2023 Dec 11
- Join now to see all
Journal Articles
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerBradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology
Authored Content
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerOctober 2018
Press Mentions
- Atlanta Hawks Launch Third Annual ‘Black History Month Assist Challenge’ to Support the Prostate Cancer FoundationFebruary 4th, 2021
- Atlanta Hawks Launch ‘Black History Month Assist Challenge’ for Prostate Cancer AwarenessJanuary 28th, 2021
- Some Cancer Patients Can Find It Hard to Tell Family and FriendsMarch 29th, 2024
Grant Support
- Minority Predoctoral Fellowship ProgramNational Cancer Institute1999–2003
- Minority Predoctoral Fellowship ProgramNational Heart, Lung, And Blood Institute1998
Professional Memberships
- Member
Hospital Affiliations
- Emory University HospitalAtlanta, Georgia
- Southern Regional Medical CenterRiverdale, Georgia
- Emory University Hospital MidtownAtlanta, Georgia
- Emory Saint Joseph's HospitalAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: